Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Metabolism of Linerixibat in Healthy Males
NCT03992014Phase 1Completed
- Sponsor
- GSK
- Start
- Jul 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of linerixibat in cholestasis and primary biliary cholangitis (PBC), sponsored by GSK. Primary endpoints: Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinite Time, Area Under the Concentration-time Curve From Time Zero to Last Time of Quantifiable Concentration and 8 more. Started Jul 2019; status: completed.
02
Drugs
linerixibat
03
Conditions
cholestasisprimary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT03992014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03992014.